Back to Search Start Over

Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis.

Authors :
Lacedonia D
Scioscia G
Soccio P
Conese M
Catucci L
Palladino GP
Simone F
Quarato CMI
Di Gioia S
Rana R
Sollitto F
Foschino-Barbaro MP
Source :
BMC pulmonary medicine [BMC Pulm Med] 2021 Jun 04; Vol. 21 (1), pp. 188. Date of Electronic Publication: 2021 Jun 04.
Publication Year :
2021

Abstract

Background: Idiopathic Pulmonary Fibrosis (IPF) is a degenerative interstitial lung disease with both a poor prognosis and quality of life once the diagnosis is made. In the last decade many features of the disease have been investigated to better understand the pathological steps that lead to the onset of the disease and, moreover, different types of biomarkers have been tested to find valid diagnostic, prognostic and therapy response predictive ones. In the complexity of IPF, microRNA (miRNAs) biomarker investigation seems to be promising.<br />Methods: We analysed the expression of five exosomal miRNAs supposed to have a role in the pathogenesis of the disease from serum of a group of IPF patients (nā€‰=ā€‰61) and we compared it with the expression of the same miRNAs in a group of healthy controls (nā€‰=ā€‰15).<br />Results: In the current study what emerged is let-7d down-regulation and, unexpectedly, miR-16 significant down-regulation. Moreover, through a cross-sectional analysis, a clustering of the expression of miR-16, miR-21 and miR-26a was found.<br />Conclusions: These findings could help the individuation of previously unknown key players in the pathophysiology of IPF and, most interestingly, more specific targets for the development of effective medications.

Details

Language :
English
ISSN :
1471-2466
Volume :
21
Issue :
1
Database :
MEDLINE
Journal :
BMC pulmonary medicine
Publication Type :
Academic Journal
Accession number :
34088304
Full Text :
https://doi.org/10.1186/s12890-021-01550-2